abstract |
The present invention relates to a biomarker composition for diagnostic use of moyamoya disease comprising caveolin-1, a diagnostic composition, a diagnostic kit, a diagnostic information providing method, and a therapeutic agent screening method. According to the present invention, since it is possible to treat moyamoya disease distinctively from atherosclerosis, which is a pseudoaneurysmal artery stenosis disease, it is possible to avoid the risk factors that unnecessary or side effects may accompany, It can be applied to therapy. |